Clinical Trials Logo

Sleep Disturbances clinical trials

View clinical trials related to Sleep Disturbances.

Filter by:

NCT ID: NCT01942733 Completed - Sleep Disturbances Clinical Trials

Study of Brexpiprazole as Adjunctive Treatment of Sleep Disturbances in Patients With Major Depressive Disorder

Start date: September 2013
Phase: Phase 3
Study type: Interventional

To assess effects of brexpiprazole on sleep patterns of depressed patients with sleep disturbances.

NCT ID: NCT01907711 Recruiting - Clinical trials for Cognitive Impairment

Clinical Trial to Evaluate the Effectiveness of Acupuncture as a Treatment in Patients Diagnosed With CFS.

AV/AS
Start date: February 2013
Phase: Phase 2/Phase 3
Study type: Interventional

background: The Chronic Fatigue Syndrome (CFS) presents many disturbances multidimensional affect holistically to people who have the disease and current management of fatigue, pain, anxiety, depression and sleep disturbances present in this clinical entity is unsatisfactory. Hypothesis: The hypothesis of this essay is to contrast that acupuncture is more useful than placebo. The investigators suggest the use of a clinical study protocol (PEC), randomized, placebo-controlled, acupuncture technique, aimed at increasing the patient's sense of well-being, relief of pain and stiffness, acupuncture is effective to reduce fatigue, anxiety, depression and sleep disorders in patients diagnosed with CFS.

NCT ID: NCT01855126 Completed - Sleep Disturbances Clinical Trials

Individually Tailored Lighting System to Improve Sleep in Older Adults

Start date: March 2013
Phase: N/A
Study type: Interventional

In conjunction with investigators at the Cecil G. Sheps Center for Health Services Research, University of North Carolina (UNC) at Chapel Hill, we propose to develop and evaluate a low-cost, minimally obtrusive device that delivers individualized light therapy to adults with early-awakening insomnia - the most common sleep disturbance in older adults, and a significant problem because of its relationship to daytime sleepiness, use of potentially hazardous sleep medication, and reduced quality of life. The proposed device will measure light/dark exposure data over 24 hours, estimate optimum timing for light delivery, and deliver an individualized light dosage while subjects are asleep. Light applied through closed eyelids in the early part of the night will delay the dim light melatonin onset, a marker of the circadian clock, and help those with early sleep onset to fall asleep later

NCT ID: NCT01816152 Completed - Depression Clinical Trials

Methodology Issues in a Tailored Light Treatment for Persons With Dementia

Start date: January 1, 2020
Phase: N/A
Study type: Interventional

Tailored light treatment will increase sleep efficiency, reduce depression and reduce agitation scores in those with Alzheimer's disease and related dementia

NCT ID: NCT01442610 Completed - Sleep Disturbances Clinical Trials

Effects of Rasagiline on Sleep Disturbances in Parkinson's Disease

RaSPar
Start date: October 2011
Phase: Phase 4
Study type: Interventional

As the MAO-B inhibitor rasagiline is able to improve motor skills it might have positive effects on sleep disruption by reducing nocturnal akinesia. As it was reported to cause only minor sleep disruption in PD Patients, it might be able to improve sleep architecture. The investigators thus study the effects of Rasagiline on sleep disturbances measured by polysomnographic (PSG) evaluation of sleep efficacy and PDSS-2. Secondary measures are other sleep variables measured by PSG, sleep quality and daytime sleepiness assessed by standardized scales as well as cognitive function, depression and QoL index.

NCT ID: NCT01429636 Completed - Hot Flashes Clinical Trials

Applied Relaxation (AR) Technique Versus Its Modified Version for Treating Menopausal Symptoms

Start date: August 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate better efficacy and effectiveness of modified applied relaxation technique over its original version for treating menopausal symptoms.

NCT ID: NCT01311193 Completed - Depression Clinical Trials

Circadian Sleep-wake Cycles and Light Therapy in Borderline Personality Disorder

Start date: n/a
Phase: N/A
Study type: Interventional

Individuals with borderline personality disorder (BPD) frequently suffer from emotional instability, daytime fatigue and sleep disturbances. The investigators examined circadian rhythms, sleep and well-being in women with BPD under their habitual life conditions with and without light treatment. Treated women diagnosed with BPD were investigated during 3 weeks without and 3 weeks with morning LT. Rest-activity cycles were continuously measured using wrist actigraphy, together with proximal skin temperature. Saliva samples were collected weekly to determine the diurnal melatonin rhythm. A range of self-ratings and questionnaires were used to assess depression and clinical state throughout the 6-week protocol. Ten matched healthy women followed the same 6-week protocol without light treatment.

NCT ID: NCT01032473 Recruiting - Clinical trials for Generalized Anxiety Disorder

Mechanisms of Sleep Disturbance in Children With Generalized Anxiety Disorder (GAD)

Start date: August 2009
Phase: N/A
Study type: Observational

Anxiety disorders are among the most common mental disorders in children, affecting approximately 1 out of every 10 children and adolescents. Symptoms of anxiety disorders may include excessive fear/anxiety/worry, somatic complaints such as headaches and muscle aches, and impaired social and family relationships. Some children with anxiety also experience sleep problems, however, little is known about the sleep patterns of anxious children. The purpose of the study, conducted at Children's National Medical Center, is to examine the sleep characteristics of children with Generalized Anxiety Disorder (GAD) compared to a control group of children without GAD to see how sleep behaviors and daytime behaviors are related.